Our present results allow a cautious conclusion that the potent inhibition of glioblastoma cell viability may be achieved by combining MRP1 inhibitors with PDE inhibitors, especially the PDE10A inhibitor PF-2545920. This evidence concerns the gene ABCC1 and glioblastoma.